Amarin, Apple, and the last CETP standing

Is there still hope for an all-but-abandoned heart drug? Are cardiologists buying into the latest data on prescription fish oil? And does the Apple Watch have a future in medicine?

Those questions will be answered (or at least addressed) this weekend at the annual meeting of the American College of Cardiology. Our own Matthew Herper will be on the ground in New Orleans to cover the news, dishing on the biggest presentations, getting exclusive interviews, and taking the pulse of the heart world’s biggest gathering.

You can read his preview of all ACC has to offer right here, and you can get his continuing coverage in your inbox via our free pop-up newsletter, ACC in 30 Seconds, which will be delivered daily during the conference.